Publications by authors named "Michael A Partridge"

Claim this Profile
A
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics.
Susan C Irvin, Samit Ganguly, Zhiqiang Wang, Zhongqing Will He, Marguerite Alejandro, Michael A Partridge

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays.
Michael A Partridge, Lynn Kamen, Bonnie Wu, Helene Solberg, Jim McNally

AAPS J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.
Sophie Shubow, Michele Gunsior, Amy Rosenberg, Yow-Ming Wang, Tara Altepeter, Michael A Partridge

AAPS J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).
Omar Tounekti, Sandra Prior, Sarah Wassmer, Joshua Xu, Adrian Wong, Michael A Partridge

Bioanalysis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging the Standard Immunogenicity Assessment Approach: 1-Tiered ADA Testing Strategy in Clinical Trials.
Ching-Ha Lai, Mu Chen, Sasha Fraser, Jessica Wang, Sean McAfee, Michael A Partridge

AAPS J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.
Mohamed A Kamal, Matthew P Kosloski, Ching-Ha Lai, Michael A Partridge, Manoj Rajadhyaksha

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.
John D Davis, Marçal Bravo Padros, Daniela J Conrado, Samit Ganguly, Xiaowen Guan, Michael A Partridge

Clin Pharmacol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor Types.
Jenny L Valentine, Andrew Dengler, An Zhao, Tiffany Truong, Sean McAfee, Michael A Partridge

J Clin Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical Approaches for Establishing Appropriate Immunogenicity Assay Cut Points: Impact of Sample Distribution, Sample Size, and Outlier Removal.
John Garlits, Sean McAfee, Jessica-Ann Taylor, Enoch Shum, Qi Yang, Michael A Partridge

AAPS J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody Assay.
Michael A Partridge, Jihua Chen, Elif Kabuloglu Karayusuf, Thanoja Sirimanne, Colin Stefan

AAPS J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium.
Marta Starcevic Manning, Mohamed Hassanein, Michael A Partridge, Vibha Jawa, Johanna Mora

AAPS J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy.
Susan C Irvin, Amanda D'Orvilliers, Nicolin Bloch, Kayla Boccio, Jason Pennucci, Michael A Partridge

AAPS J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry ( - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation).
Sarah Hersey, Steve Keller, Joel Mathews, Lindsay King, Abbas Bandukwala, Michael A Partridge

Bioanalysis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay pH and critical reagent optimization in measuring concentrations of a monoclonal antibody and its target.
Jihua Chen, Kimberly Kendra, Stacey Shank, Ashique Rafique, George Ehrlich, Michael A Partridge

Bioanalysis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGEN-COV antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification.
Susan C Irvin, Samit Ganguly, Rachel Weiss, Chinnasamy Elango, Xuefei Zhong, Michael A Partridge

Bioanalysis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of reduced IL-33 levels in human serum: mitigating interference from endogenous binding partners.
Joshua Zylstra, Michael A Partridge, Giane Sumner

Bioanalysis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays.
Andrew F Dengler, Rachel Weiss, Tiffany Truong, Susan C Irvin, Nidhi Gadhia, Michael A Partridge

AAPS J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Therapeutic Antibody Cocktail REGEN-COV Concentrations in COVID-19 Patient Serum.
Xuefei Zhong, Shruti Nayak, Lili Guo, Shivkumar Raidas, Yunlong Zhao, Michael A Partridge

Anal Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotyping and Semi-Quantitation of Monkey Anti-Drug Antibodies by Immunocapture Liquid Chromatography-Mass Spectrometry.
Xiaoxiao Huang, Xiaobin Xu, Michael A Partridge, Jihua Chen, Ellen Koehler-Stec

AAPS J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of clinically relevant immunogenicity for mAbs; are we over reporting ADA?
Mohamed Hassanein, Michael A Partridge, Weiping Shao, Albert Torri

Bioanalysis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data.
Michael A Partridge, Elif Kabuloglu Karayusuf, Gary Shyu, Camille Georgaros, Albert Torri

AAPS J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc-Fc interactions.
Michael A Partridge, Uma Vijayam, Elif Kabuloglu Karayusuf, Enoch Shum, Thanoja Sirimanne

Bioanalysis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.
Michael A Partridge, Shobha Purushothama, Chinnasamy Elango, Yanmei Lu

J Immunol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development.
Yanmei Lu, Leslie A Khawli, Shobha Purushothama, Frank-Peter Theil, Michael A Partridge

J Immunol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix interference from Fc-Fc interactions in immunoassays for detecting human IgG4 therapeutics.
Michael A Partridge, Elif Kabuloglu Karayusuf, Gangadhar Dhulipala, Robert Dreyer, Thomas Daly

Bioanalysis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis